Australia's most trusted
source of pharma news
Tuesday, 11 November 2025
Posted 10 November 2025 AM
The TGA has registered a new influenza vaccine from Sanofi on the TGA, under the Vaxigrip brand. It's a trivalent vaccine targeting two influenza A subtypes and one influenza B subtype, indicated for people above six months of age.
Meanwhile, Accord has joined the fight for denosumab market share, registering four brands. Generics Dostiva and Dexeva target Amgen's Xgeva, while Denolia and Deskeltia target Amgen's Prolia.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.